(
EMAILWIRE.COM, December 05, 2017 ) North America Western Blotting Market 2017-2021: Market is Anticipated to Expand at a Significant CAGR of 5.2%
North America Western blotting market is expected to grow at a 5.2% CAGR from 2016 to 2021 and it is estimated that the North-America market was valued at USD 201.18 million in 2016 and is relied upon to achieve USD 259.22 million by 2021.
Western blot is often used in research to separate and identify proteins. In this technique, a mixture of proteins is separated based on molecular weight, and thus by type, through gel electrophoresis. These results are then transferred to a membrane producing a band for each protein. The membrane is then incubated with labels antibodies specific to the protein of interest. The unbound antibody is washed off leaving only the bound antibody to the protein of interest. The bound antibodies are then detected by developing the film. As the antibodies only bind to the protein of interest, only one band should be visible. The thickness of the band corresponds to the amount of protein present; thus, doing a standard can indicate the amount of protein present.
Get a comprehensive overview of the Market:
http://marketdataforecast.com/market-reports/north-america-western-blotting-market-5087/ Increasing research activities and R&D spending by pharmaceutical and biotechnology companies and rise in the prevalence of HIV/AIDS are the primary driving factors of the market. Factors such as growth in proteomics market, the increasing number of industry-academic research collaborations, increase in requirement for personalized medicine, and new product launches are further expected to aid the growth of the market. On the other hand, the emergence of alternative technologies is anticipated to have a negative impact on the growth of the market. Furthermore, strict regulations and requirement of high procedural efficiency for accurate results are likely to challenge the market in the coming years. However, automation in western blotting instruments is expected to provide lucrative opportunities for the market.
Request for sample Brochure:
http://marketdataforecast.com/market-reports/north-america-western-blotting-market-5087/request-sample The North-America market for Western Blotting market is segmented into Product, Application and End User. On the basis of product, it is segmented into Instruments and Consumables. The consumables segment holds the largest share in this segment of the market. This is primarily due because of rise in the use of western blotting in research & diagnosis and increase in the number of incidences of diseases requiring western blotting for diagnosis. The instruments market is further segmented into gel electrophoresis instruments, blotting systems, and images. The blotting systems segment is expected to account for the largest share in this market segment. The large share of this segment can be credited to its high sensitivity, low run time, and high efficiency. On the basis of application, it is segmented into Biomedical & Biochemical Research and Disease Diagnostics. The biomedical & biochemical research segment is anticipated to hold the largest share of this market segment. This is primarily due to the surge in government spending on proteomics research, and an increase in R&D spending by pharmaceutical & biotechnology companies in drug discovery and development. However, the disease diagnostics segment is projected to grow at the highest in the coming years. This can be credited to rise in prevalence and incidences of HIV, HSV, HBV, and Lyme disease, among others. On the basis of end user, it is segmented into Academic & Research Institutes and Pharmaceutical & Biotechnology Companies. Pharmaceutical and biotech companies segment will lead with the maximum share of this market segment. However, research institutions segment is anticipated to have the highest growth rate, followed by diagnostic laboratories segment with the smallest share in this market segment.
Inquire Before Buying:
http://marketdataforecast.com/market-reports/north-america-western-blotting-market-5087/inquire On the basis of geography, the market is analyzed under various regions namely U.S. and Canada. North-America accounts for the largest share of the market. This can be attributed to the rise in the prevalence of HIV and Lyme disease, U.S.–China combined program for biomedical research, upsurge in research funding and rise in the production of genetically modified crops in the U.S., HIV vaccine initiative, and growth in the intensity of pharmaceutical and biopharmaceutical clinical research in Canada
The market is dominated by companies such as Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., GE Healthcare, Advansta, Inc., LI-COR Biosciences, PerkinElmer Inc., Bio-Techne Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd., and Cell Signaling Technology.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.comSource:
EmailWire.Com 
